Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “GSK”

A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy VolunteersCompleted
NCT01114841Phase 1Updated Jun 14, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male VolunteersCompleted
NCT01702493Phase 1Updated Jun 12, 2017
Sponsor: Sirtris, a GSK Company
Psoriasis
United States
A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male SubjectsCompleted
NCT00937872Phase 1Updated Jun 5, 2017
Sponsor: Sirtris, a GSK Company
Diabetes Mellitus, Type 2
United Kingdom
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative ColitisCompleted
NCT01453491Phase 1Updated Jun 1, 2017
Sponsor: Sirtris, a GSK Company
Colitis, Ulcerative
United States
A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT GelCompleted
NCT00689117Phase 3Updated May 30, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris · Acne
United States, Belize, Canada
A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male VolunteersCompleted
NCT00933530Phase 1Updated May 30, 2017
Sponsor: Sirtris, a GSK Company
Diabetes Mellitus, Type 2 · Healthy Volunteer
United Kingdom
Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne MedicationsCompleted
NCT00964366Phase 4Updated May 30, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)Completed
NCT00509275Phase 1Updated May 30, 2017
Sponsor: Stiefel, a GSK Company
Tinea Pedis
United States, Australia
Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne VulgarisCompleted
NCT00160394Phase 4Updated May 30, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
Poland, United Kingdom
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial AcneCompleted
NCT00841776Phase 4Updated May 25, 2017
Sponsor: Stiefel, a GSK Company
Acne
United States
Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate AcneCompleted
NCT00837213Phase 4Updated May 25, 2017
Sponsor: Stiefel, a GSK Company
Acne
United States
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With AcneCompleted
NCT01446237NAUpdated May 25, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO WashCompleted
NCT00891982Phase 3Updated May 24, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial AcneCompleted
NCT01017120Phase 3Updated May 18, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States, Canada
A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 CreamCompleted
NCT02411162Phase 1Updated May 9, 2017
Sponsor: Stiefel, a GSK Company
Dermatitis, Atopic
United States
8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat AcneCompleted
NCT02524665Phase 4Updated Apr 13, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical MedicationsCompleted
NCT01015638Phase 4Updated Mar 31, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSACompleted
NCT00852540Phase 3Updated Mar 27, 2017
Sponsor: Stiefel, a GSK Company
Skin Infections, Bacterial
United States
Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With AcneCompleted
NCT00713609Phase 2Updated Mar 6, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.Completed
NCT00356915Phase 3Updated Feb 9, 2017
Sponsor: Stiefel, a GSK Company
Onychomycosis
United States, Canada, Dominican Republic, Ecuador, Honduras +2 more
A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne VulgarisCompleted
NCT01016977Phase 4Updated Jan 30, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%Completed
NCT00703846Phase 4Updated Jan 30, 2017
Sponsor: Stiefel, a GSK Company
Dermatitis, Seborrheic
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301Completed
NCT01017146Phase 3Updated Jan 18, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States, Canada
The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body PsoriasisCompleted
NCT01139580Phase 3Updated Jan 18, 2017
Sponsor: Stiefel, a GSK Company
Psoriasis
United States
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 StudiesCompleted
NCT00688519Phase 3Updated Jan 2, 2017
Sponsor: Stiefel, a GSK Company
Psoriasis
United States

Previous page Next page